Monday, October 22, 2018
- 9:00AM-11:00AM
-
Abstract Number: 1527
Tofacitinib Improves Left Ventricular Mass and Cardiac Output in Rheumatoid Arthritis Patients with Chronic Heart Failure
Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 1544
Tofacitinib Safety and Efficacy in the Treatment of Rheumatoid Arthritis in a Central/Eastern European Subpopulation
Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 1531
Tofacitinib Show Similar Retention When Used with and without Methotrexate. Analysis from the Rhumadata® Clinical Database and Registry
Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 1317
Tracheomalacia in Coventry in UK
Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis- 9:00AM-11:00AM
-
Abstract Number: 1141
Trajectories of Extensive Sitting and Associated Predictors in Persons at High Risk for Knee Osteoarthritis
Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function- 9:00AM-11:00AM
-
Abstract Number: 1705
Trajectory Analysis of Combined Disease Activity and Physical Component Summary Scale in an Inception Cohort of Adults with Systemic Lupus Erythematosus: Latent Classes Inform Different Patterns
Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 998
Transcription Factor Fli-1 Impacts Renal IL-17 Expression in Adult MRL/Lpr Mouse Despite Similar Interstitial Immune Cell Infiltration into the Kidney
Cytokines and Cell Trafficking Poster- 9:00AM-11:00AM
-
Abstract Number: 1438
Treatment and Response of Down Syndrome Arthropathy
Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 1364
Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 “Pain on Walking” – Results from a 52-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor
Osteoarthritis – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1217
Trend of Frequency and Outcome of Reactive Arthritis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy over the Last 20 Years
Infection-related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 1142
Trend of Lymphoma Incidence in US Veterans with Rheumatoid Arthritis Vs Osteoarthritis: 2002-2017
Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function- 9:00AM-11:00AM
-
Abstract Number: 1443
Ultrasonographic Criteria for the Diagnosis of Erosive Rheumatoid Arthritis Disease Using Osteoarthritic Patients As Controls Compared to Validated Radiographic Criteria
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis- 9:00AM-11:00AM
-
Abstract Number: 1632
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon